The company currently trades on the Canadian Securities Exchange, where its market performance has been aggressive. Shares have climbed more than 52% since January, finishing Monday’s session at 18.15 Canadian dollars, or roughly $13.01. This repurchase initiative coincides with the firm’s transition toward major U.S. exchange exposure, marking a significant milestone as the first cannabis entity to receive such approval. Management retains the flexibility to execute these buybacks over the coming twelve-month window, signaling confidence in the current valuation as the company prepares to shift its primary trading venue.